Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Int Immunopharmacol ; 84: 106557, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32388491

RESUMEN

The intestinal microbiota plays a critical role in food allergy development. However, little is known regarding the structure and composition of the intestinal microbiota in patients with wheat-dependent exercise-induced anaphylaxis (WDEIA). We examined the gut microbiota alterations in patients with WDEIA and the microbiota's association with WDEIA. Fecal samples were collected from 25 patients with WDEIA and 25 healthy controls. Environmental exposure factors were obtained, serum total IgE, IgE specific to wheat, gluten, and ω-5 gliadin were measured. Fecal samples were profiled using 16S rRNA gene sequencing. The relative abundances of the bacterial genera Blautia (P < 0.05), Erysipelatoclostridium (P < 0.01), Akkermansia (P < 0.05) and Lachnospiraceae_NK4A136_group (P < 0.05) were significantly increased, while those of Lactobacillus (P = 0.001) and Dialister (P < 0.05) were significantly decreased in subjects with WDEIA. The microbial diversity did not differ between WDEIA patients and healthy controls. IgE specific to ω-5 gliadin was positively associated with the Oscillospira (r = 0.48, P < 0.05) and negatively associated with Leuconostoc (r = -0.49, P < 0.05). Total IgE levels were significantly negatively correlated with Bifidobacterium (P < 0.05). The gut microbiome compositions in WDEIA patients differed from those of healthy controls. We identified a potential association between the gut microbiome and WDEIA development. Our findings may suggest new methods for preventing and treating WDEIA.


Asunto(s)
Anafilaxia/microbiología , Ejercicio Físico , Microbioma Gastrointestinal , Hipersensibilidad al Trigo/microbiología , Adolescente , Adulto , Anafilaxia/sangre , Anafilaxia/etiología , Anafilaxia/inmunología , Bacterias/genética , Bacterias/aislamiento & purificación , Heces/microbiología , Femenino , Gliadina/inmunología , Glútenes/inmunología , Humanos , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Masculino , Persona de Mediana Edad , ARN Ribosómico 16S/genética , Triticum/inmunología , Hipersensibilidad al Trigo/sangre , Hipersensibilidad al Trigo/complicaciones , Hipersensibilidad al Trigo/inmunología , Adulto Joven
2.
Nutrients ; 11(10)2019 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-31581491

RESUMEN

Gluten-related disorders include distinct disease entities, namely celiac disease, wheat-associated allergy and non-celiac gluten/wheat sensitivity. Despite having in common the contact of the gastrointestinal mucosa with components of wheat and other cereals as a causative factor, these clinical entities have distinct pathophysiological pathways. In celiac disease, a T-cell mediate immune reaction triggered by gluten ingestion is central in the pathogenesis of the enteropathy, while wheat allergy develops as a rapid immunoglobulin E- or non-immunoglobulin E-mediated immune response. In non-celiac wheat sensitivity, classical adaptive immune responses are not involved. Instead, recent research has revealed that an innate immune response to a yet-to-be-defined antigen, as well as the gut microbiota, are pivotal in the development in this disorder. Although impairment of the epithelial barrier has been described in all three clinical conditions, its role as a potential pathogenetic co-factor, specifically in celiac disease and non-celiac wheat sensitivity, is still a matter of investigation. This article gives a short overview of the mucosal barrier of the small intestine, summarizes the aspects of barrier dysfunction observed in all three gluten-related disorders and reviews literature data in favor of a primary involvement of the epithelial barrier in the development of celiac disease and non-celiac wheat sensitivity.


Asunto(s)
Enfermedad Celíaca/metabolismo , Glútenes/metabolismo , Absorción Intestinal , Mucosa Intestinal/metabolismo , Intestino Delgado/metabolismo , Hipersensibilidad al Trigo/metabolismo , Animales , Bacterias/inmunología , Bacterias/metabolismo , Enfermedad Celíaca/tratamiento farmacológico , Enfermedad Celíaca/inmunología , Enfermedad Celíaca/microbiología , Fármacos Gastrointestinales/uso terapéutico , Microbioma Gastrointestinal , Glútenes/inmunología , Interacciones Huésped-Patógeno , Humanos , Inmunidad Innata , Absorción Intestinal/efectos de los fármacos , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/inmunología , Mucosa Intestinal/microbiología , Intestino Delgado/efectos de los fármacos , Intestino Delgado/inmunología , Intestino Delgado/microbiología , Oligopéptidos/uso terapéutico , Permeabilidad , Transducción de Señal , Proteínas de Uniones Estrechas/metabolismo , Hipersensibilidad al Trigo/tratamiento farmacológico , Hipersensibilidad al Trigo/inmunología , Hipersensibilidad al Trigo/microbiología
3.
Nutrients ; 9(11)2017 Nov 02.
Artículo en Inglés | MEDLINE | ID: mdl-29099090

RESUMEN

Non-coeliac/non-allergic gluten/wheat sensitivity (NCG/WS) is a gluten-related disorder, the pathogenesis of which remains unclear. Recently, the involvement of an increased intestinal permeability has been recognized in the onset of this clinical condition. However, mechanisms through which it takes place are still unclear. In this review, we attempt to uncover these mechanisms by providing, for the first time, an integrated vision of recent scientific literature, resulting in a new hypothesis about the pathogenic mechanisms involved in NCG/WS. According to this, the root cause of NCG/WS is a particular dysbiotic profile characterized by decreased butyrate-producing-Firmicutes and/or Bifidobacteria, leading to low levels of intestinal butyrate. Beyond a critical threshold of the latter, a chain reaction of events and vicious circles occurs, involving other protagonists such as microbial lipopolysaccharide (LPS), intestinal alkaline phosphatase (IAP) and wheat α-amylase trypsin inhibitors (ATIs). NCG/WS is likely to be a multi-factor-onset disorder, probably transient and preventable, related to quality and balance of the diet, and not to the presence of gluten in itself. If future studies confirm our proposal, this would have important implications both for the definition of the disease, as well as for the prevention and therapeutic-nutritional management of individuals with NCG/WS.


Asunto(s)
Bifidobacterium/crecimiento & desarrollo , Enfermedad Celíaca/microbiología , Disbiosis , Firmicutes/crecimiento & desarrollo , Microbioma Gastrointestinal , Glútenes/administración & dosificación , Intestinos/microbiología , Triticum/efectos adversos , Hipersensibilidad al Trigo/microbiología , Animales , Bifidobacterium/metabolismo , Butiratos/metabolismo , Enfermedad Celíaca/clasificación , Enfermedad Celíaca/diagnóstico , Enfermedad Celíaca/inmunología , Medicina Basada en la Evidencia , Firmicutes/metabolismo , Glútenes/inmunología , Humanos , Absorción Intestinal , Permeabilidad , Pronóstico , Factores de Riesgo , Triticum/inmunología , Hipersensibilidad al Trigo/clasificación , Hipersensibilidad al Trigo/diagnóstico , Hipersensibilidad al Trigo/inmunología
4.
Curr Gastroenterol Rep ; 18(7): 36, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27216895

RESUMEN

Celiac disease is the most common oral intolerance in Western countries. It results from an immune response towards gluten proteins from certain cereals in genetically predisposed individuals (HLA-DQ2 and/or HLA-DQ8). Its pathogenesis involves the adaptive (HLA molecules, transglutaminase 2, dendritic cells, and CD4(+) T-cells) and the innate immunity with an IL-15-mediated response elicited in the intraepithelial compartment. At present, the only treatment is a permanent strict gluten-free diet (GFD). Multidisciplinary studies have provided a deeper insight of the genetic and immunological factors and their interaction with the microbiota in the pathogenesis of the disease. Similarly, a better understanding of the composition of the toxic gluten peptides has improved the ways to detect them in food and drinks and how to monitor GFD compliance via non-invasive approaches. This review, therefore, addresses the major findings obtained in the last few years including the re-discovery of non-celiac gluten sensitivity.


Asunto(s)
Enfermedad Celíaca/genética , Enfermedad Celíaca/inmunología , Hipersensibilidad al Trigo/genética , Hipersensibilidad al Trigo/inmunología , Enfermedad Celíaca/microbiología , Dieta Sin Gluten , Epigénesis Genética , Microbioma Gastrointestinal , Glútenes/inmunología , Humanos , Fenómenos Inmunogenéticos , Hipersensibilidad al Trigo/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...